Before coming to Eindhoven, I studied metal craftsmanship at Ecole Boulle. This school teaches students the traditional French craft heritage. There, I learned to have a good vision in 3D, precise technical skills and an eye for quality. Some aspects of this education have remained strongly in my mind: as we were forging our own tools with a fire torch and a hammer, I designed my own tools -all laser cut in steel- to construct the ‘Regen’ garments and accessories. I also love all the little technical tricks that make crafts and techniques being so smart. And to conclude, I really enjoy the craftsman routine: spending time in an atelier, being physically active and focused, trying out different tools, making a mess, and having the greatest satisfactory feeling when all the products are finally done and the atelier is clean again.
What fascinates you about designing materials?
First of all I would say that I am a materialist and therefore, I like to touch and feel the matter. I like the weight, the texture and the smell of things. I feel connected to the materials because my senses can relate to them. I like the smell of Argon when I weld, the smell of sheep when I work with wool, the smell of latex when I work on ‘Regen’. All these details give an atmosphere to my days. Besides this, I am seeking unexpected outcomes from common materials. I enjoy playing with their limits, or combine them to extract possibilities they haven’t given yet. When I manage to get a surprising effect, then I feel that I have achieved my goal.
Can you describe your creative process?
Thalidomide has been used by Brazilian physicians as the drug of choice for the treatment of severe ENL since 1965, and by 1996, at least 33 cases of thalidomide embryopathy were recorded in people born in Brazil after 1965.  Since 1994, the production, dispensing, and prescription of thalidomide have been strictly controlled, requiring women to use two forms of birth control and submit to regular pregnancy tests. Despite this, cases of thalidomide embryopathy continue,   with at least 100 cases identified in Brazil between 2005 and 2010.  million thalidomide pills were distributed throughout Brazil in this time period, largely to poor Brazilians in areas with poor access to healthcare, and these cases have occurred despite the controls.